May 2026

First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with chemotherapy in first-line non-small cell lung …

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

CGTN: China-Africa ties at 70: From shared struggles to a common dream of modernization

Village Voyage: Where China’s rural soul meets the world

AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech

Vietnam Tightens Entry Compliance as Foreign Visitor Numbers Surge

Japan seeks candid dialog, defense minister says, rejecting ‘neo-militarism’ claims

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

China is ‘losing a chance’ by not being at the Shangri-La Dialogue: German defense chief

The Philippines is in for a ‘long-term struggle’ with China over territory, Manila’s defense secretary tells CNBC

ENERtec Asia 2026 Partners with MIDA to Power Malaysia’s Digital Economy via Renewable Energy and Battery Storage Innovation